Trials / Completed
CompletedNCT06613828
Efficacy of Five Strategies To Improve Stroke Awareness in the Spanish-Speaking Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 435 (actual)
- Sponsor
- Instituto Mexicano del Seguro Social · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this experimental study is to evaluate the efficacy of five educational strategies for recognizing early symptoms of cerebrovascular disease (CVD) in the general adult population. The main questions it aims to answer are: \- How effective are the strategies RAPIDO, CORRE, DALE, CAMALEON, and ICTUS 911 in improving the recognition of early CVD symptoms? Researchers will compare these strategies to determine which one leads to the highest increase in symptom recognition. Participants will receive a brief educational session on one of the five strategies and will: * Complete a pre- and post-intervention survey (Stroke Awareness Questionnaire, SAQ). * Receive short training on CVD symptoms and the urgency of contacting emergency services. The primary outcome is the improvement in SAQ scores, and the secondary outcome is the proportion of participants achieving adequate knowledge of CVD symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mnemonic-Based Educational Training for Stroke Symptom Recognition | This is a Culturally Adapted Mnemonic-Based Educational Strategies for Rapid Stroke Symptom Recognition in the Spanish-Speaking Population. It uses five distinct mnemonic strategies (RAPIDO, CORRE, DALE, CAMALEON, ICTUS 911), each specifically tailored for a Spanish-speaking audience. Aims to improve the recognition of early cerebrovascular disease symptoms, differentiating it from other clinical studies that might focus on different health conditions or target populations. Emphasizes its focus on rapid action by educating participants about stroke symptoms and the importance of contacting emergency services (911). |
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2024-10-20
- Completion
- 2024-11-07
- First posted
- 2024-09-26
- Last updated
- 2025-05-01
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT06613828. Inclusion in this directory is not an endorsement.